| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/03/2008 | WO2008078686A1 Oxime ester compound and photopolymerization initiator comprising the compound |
| 07/03/2008 | WO2008078678A1 Oxime ester compound and photopolymerization initiator containing the compound |
| 07/03/2008 | WO2008077917A1 Process for preparing (r or s)-2-alkyl-3-heterocyclyl-1-propanols |
| 07/03/2008 | WO2008077871A1 Salts of tegaserod |
| 07/03/2008 | US20080161581 Synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161347 Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161323 Piperazine Derivatives of Alkyl Oxindoles |
| 07/03/2008 | US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use |
| 07/03/2008 | US20080160627 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection |
| 07/03/2008 | CA2685198A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 07/03/2008 | CA2672620A1 Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
| 07/02/2008 | EP1939182A1 Process for the preparation of (R or S)-2-Alkyl-3-heterocyclyl-1-propanols |
| 07/02/2008 | EP1939176A1 Salts of Tegaserod |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1756142B1 Pseudopeptides growth hormone secretagogues |
| 07/02/2008 | EP1633702B1 Protease inhibitors |
| 07/02/2008 | EP1569911B1 Indazole derivatives as crf antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
| 07/02/2008 | CN101213190A Compounds and compositions as TPO mimetics |
| 07/02/2008 | CN101213175A Bicyclic derivatives as p38 kinase inhibitors |
| 07/02/2008 | CN101213174A Oxindole compounds and their uses as therapeutic agents |
| 07/02/2008 | CN101213173A Process for production of optically active aminopentane derivative, intermediate and process for producing the intermediate |
| 07/02/2008 | CN101213172A Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 07/02/2008 | CN101209988A Phenanthrene series derivatives and organic light-emitting diode containing the same |
| 07/02/2008 | CN100398516C Synthesis of taxol enhancers |
| 07/01/2008 | US7393960 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders |
| 06/26/2008 | WO2008077079A1 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/26/2008 | WO2008076569A1 Bis-carbazole monomers and polymers |
| 06/26/2008 | WO2008076316A2 Bisulfite purification of an alpha-keto amide |
| 06/26/2008 | WO2008075564A1 Oxime ester compound, photopolymerization initiator, photopolymerizable composition, color filter, and liquid crystal display device |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | WO2008074716A1 Azabicyclic compounds as serotonine, dopamine and norepinephrine re-uptake inhibitors |
| 06/26/2008 | WO2008074709A1 Anthraquinone derivatives as markers for liquids |
| 06/26/2008 | WO2008074692A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 06/26/2008 | WO2008074078A1 Selectively deliverable isatin-based cytotoxic agents |
| 06/26/2008 | WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | US20080154046 Imidoalkanpercarboxylic acids |
| 06/26/2008 | US20080154035 Coupling method between intramolecular carbon in unsaturated hydrocarbon compound using organo-indium compound as coupling agent |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153875 Novel indole derivatives and their use as medicament |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153817 Treatment for Alzheimer's Disease and Related Conditions |
| 06/26/2008 | US20080153805 Sulfonamide derivatives |
| 06/26/2008 | US20080153802 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | US20080149175 Merocyanine dyes; solar cells |
| 06/26/2008 | US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2672761A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cpti) |
| 06/26/2008 | CA2672268A1 Bisulfite purification of an alpha-keto amide |
| 06/26/2008 | CA2672205A1 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/26/2008 | CA2635847A1 Anthraquinone derivatives as markers for liquids |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935883A1 Oxindole derivative as feeding control agent |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935419A1 Hemodynamics improving agent |
| 06/25/2008 | EP1934179A2 Processes and intermediates |
| 06/25/2008 | EP1934178A2 Substituted propylamine derivatives and methods of their use |
| 06/25/2008 | EP1807398B1 New indole or benzimidazole derivatives |
| 06/25/2008 | EP1789387B1 Perfected process for the preparation of stable nitroxide radicals |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | EP0986382B1 Raf kinase inhibitors |
| 06/25/2008 | CN101208301A Bicyclic derivatives as p38 kinase inhibitors |
| 06/25/2008 | CN101205210A Indole derivatives and uses thereof |
| 06/25/2008 | CN100396678C Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390909 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes |
| 06/24/2008 | US7390827 Herbicides for selectively controlling broadleaf and gramineous weeds in crops of useful plants, especially in rice crops |
| 06/24/2008 | US7390818 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent |
| 06/19/2008 | WO2008073694A1 Carbazolyl monomers and polymers |
| 06/19/2008 | WO2008073613A2 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines |
| 06/19/2008 | WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 06/19/2008 | WO2008072539A1 Organic electroluminescence device |
| 06/19/2008 | WO2008072538A1 Organic electroluminescent device |
| 06/19/2008 | WO2008071453A1 1,2-diarylacetylene derivatives of acyltryptophanols |
| 06/19/2008 | WO2008071387A1 Prodrugs of diphenyl ox- indol- 2 -one compounds for the treatment of cancers |
| 06/19/2008 | WO2008049996A3 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 06/19/2008 | WO2008045371A3 N-substituted-azacyclylamines as histamine-3 antagonists |
| 06/19/2008 | WO2008044027A3 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 06/19/2008 | WO2007146718A3 Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino] methyl]phenyl]-2e-2-propenamide and starting materials therefor |
| 06/19/2008 | WO2007092758A3 Crystalline forms of perindopril erbumine |
| 06/19/2008 | US20080146817 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 06/19/2008 | US20080146816 Polycarbazole ; optoelectronics, signal processing, data storage; ability to change colour reversibly under the effect of light radiation |
| 06/19/2008 | US20080146811 peptidomimetics and non-peptides that inhibit the activity of Factor XIa; purified human Factor XI protein mutants |
| 06/19/2008 | US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/19/2008 | US20080146808 Antiapoptosis; cancers; inhibiting the caspases; |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146647 Acetylene derivatives having mglur 5 antagonistic activity |
| 06/19/2008 | US20080146646 For therapy of pain, inflammation, urological disorders, gynecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritation, herpes or zona, diabetes, depression |
| 06/19/2008 | US20080146645 Reacting compounds such as 7-Fluoro-3,3-dimethyl-1,3-dihydro-2H-indol-2-one with compounds such as 1R,3R)-3-(3-fluorophenyl)-2-(hydroxymethyl)oxirane in the presence of Lewis acid catalyst,a solvent and a strong non-nucleophilic base |
| 06/19/2008 | US20080146644 Tricyclic Cytoprotective Compounds |